The annual passenger flow at the West Kowloon Station Port exceeded 25 million for the first time. It was learned from the West Kowloon Border Inspection Station of Shenzhen Border Inspection Station that as of 24: 00 on December 11th, the cumulative passenger flow at the West Kowloon Border Inspection Station exceeded 25 million for the first time this year, accounting for 36.7% of the total passenger flow since the opening of the West Kowloon Station Port, an increase of 36.5% compared with last year, an increase of 33% on average daily passenger flow, and 32.5% of foreign passengers entering the country without visas. Inspection ensures that cross-border trains increase by 36% year-on-year, and "customs clearance flow" helps "economic growth", injecting border inspection momentum into the country's high-level open and high-quality development. (Voice of Greater Bay Area)The negative spread of 10-year national debt between China and the United States has expanded to nearly 250BP, which is the largest in more than 22 years.Trump said that he chose Kari Lake as the director of VOA.
The 10th anniversary of the middle route of South-to-North Water Transfer Project, today (12th) is the 10th anniversary of the middle route of South-to-North Water Transfer Project. Up to now, the project has transferred more than 10.6 billion cubic meters of water to Beijing. In the past decade, Beijing has greatly reduced the amount of groundwater exploitation and shut down more than 1,300 self-prepared wells. The groundwater level in the plain area of Beijing has risen for nine consecutive years. The groundwater depth has risen from 25.75 meters in 2015 to 12.61 meters today, and the groundwater reserves have increased by 7 billion cubic meters compared with 2015. There are 81 springs in Beijing that have re-flooded. Since 2019, the five major rivers in Beijing, Yongding River, Chaobai River, North Canal, Juma River and Chanhe River, have all been "flowing rivers" after a lapse of 26 years, and have been flowing into the sea for four consecutive years. (CCTV News)The project of Chuangpu Instrument Industrial Park started in Hefei, with a total investment of 320 million yuan. According to the news of Hefei High-tech Zone Management Committee, on December 10th, the project of Chuangpu Instrument Industrial Park at the intersection of Caihong West Road and Peacock Terrace Road in Hefei High-tech Zone officially started. The total investment of the project is 320 million yuan, which is planned to be completed at one time and is expected to be put into use in the second half of 2027.Zhengzhou plans to identify three 4A-level scenic spots. On December 12th, it was reported that through the procedures of "voluntary declaration, step-by-step recommendation, landscape review, on-site inspection and party group research", Zhengzhou Municipal Bureau of Culture, Radio, Film and Tourism plans to identify three scenic spots, including Zhongmu Zhengzhou Haichang Ocean Park, Gongyi Qinglong Mountain Ecological Tourism Zone and Guancheng Zhengzhou Shangdu Ancient City Tourist Zone, as national 4A-level tourist attractions. The publicity period is 5 working days from December 9.
Trump said that he chose Kari Lake as the director of VOA.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide